MondayApr 29, 2013 9:21 am

Cardium Therapeutics, Inc. (CXM) Looks to Future with Three-Stage Growth Plan

Cardium Therapeutics is a San Diego based health sciences and regenerative medicine company that has carefully diversified itself with a strategy designed to provide short-term, mid-term, and long-term growth and revenue. In so doing, they have successfully positioned themselves in several markets, much like a rocket with multiple stages timed for continuous acceleration. Immediate revenue is provided through Cardium’s To Go Brands subsidiary, acquired in 2012, which markets and sells a growing portfolio of over 25 healthy lifestyle products, including nutraceutical powder mixes and supplements designed for both convenience and health of active lifestyle consumers. Their product line contains 100%…

Continue Reading

MondayApr 29, 2013 8:31 am

LaserLock Technologies, Inc. (LLTI) Voices its Solution on Pharmaceutical Counterfeit to Congress

LaserLock Technologies, a provider of authentication solutions to governments, healthcare providers, high-end retailers, and the gaming industry, recently submitted health-focused testimony to the U.S. House of Representatives Subcommittee during a hearing on "Securing our Nation's Prescription Drug Supply Chain." In its testimony, LaserLock addressed Congress’ focus on anti-counterfeiting measures in the growing counterfeit pharmaceutical trade. The company’s proposed solution is an “innovative supply chain” that integrates the ubiquity of mobile devices, high-tech optics, secure anti-counterfeiting technologies, and the development of authentication databases as a secure means to track and trace prescription drugs. "We are pleased that the United States Congress…

Continue Reading

FridayApr 26, 2013 4:50 pm

Low Carbon Technologies (LWCTF) is "One to Watch"

Low Carbon Technologies International is a U.S. based diversified clean-tech holding company focused on the clean-tech, construction, energy, environmental, mining, and real estate sectors. The company’s primary focus is on generating consistent shareholder growth by minimizing expenses and increasing asset values through leveraged acquisitions. In addition to acquiring profitable companies, LWCTF’s business strategy includes the use of its various technologies in the development of clean-tech projects which are generally located on the company’s real estate assets. As an additional source of revenue, LWCTF also issues sub-licenses to third parties in exchange for a fair amount of project equity and licensing…

Continue Reading

FridayApr 26, 2013 3:38 pm

Green Technology Solutions, Inc. (GTSO) Chilerecicla Partnership Would Tap Into and Leverage Burgeoning Global E-Waste Supplier Network

Green Technology Solutions, the aggressive young company which has made a name for itself by attacking the resource equation from both the mining and recycling sides, hunting for rare earths and precious minerals with the drill and via the landfill, reported progress today in their continued negotiations (aimed at striking a definitive agreement) with Chilean recycler, Chilerecicla, who is putting together a network of e-waste suppliers in Latin America. This network would pump out valuable minerals for direct sale to overseas smelting markets and represents a huge win for Chilerecicla, who will be able to lock in favorable prices from…

Continue Reading

FridayApr 26, 2013 2:26 pm

SmallCapVoice: Marley Coffee (JAMN) Opens Up RealCups Distribution at Market Basket Stores

Marley Coffee, a sustainably grown, ethically farmed and artisan roasted gourmet coffee, announced that their RealCups, which are compatible with Keurig’s single serve K-cup machines, will become available within all 69 of Market Basket Stores at the beginning of May. Market Basket is a growing chain of 69 supermarkets in New Hampshire and Massachusetts. Supermarket News ranked Market Basket No. 43 in the 2010 “Top 75 North American Food Retailers” based on 2009 fiscal year estimated sales of $3.0 billion. The company does lots of business in the single serve space and represents a significant new area of distribution for…

Continue Reading

FridayApr 26, 2013 11:04 am

Curis, Inc. (CRIS) Receives Conditional Approval Recommendation for Erivedge from CHMP

Oncology-focused company Curis announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended conditional approval of Erivedge (vismodegib) for treating adult patients with symptomatic metastatic basal cell carcinoma, or locally advanced basal cell carcinoma that is not appropriate for surgery or radiotherapy. Receiving conditional approval would make Erivedge Europe’s first licensed treatment for patients with advanced basal cell carcinoma, which is a rare form of skin cancer that can be disfiguring, debilitating, and even fatal. “We are extremely pleased that the CHMP has recommended the conditional approval of Erivedge in…

Continue Reading

FridayApr 26, 2013 11:01 am

Mimvi, Inc. (MIMV) Launches Small Business App Development Service

Based out of California, leading mobile search and recommendation company Mimvi announced the launch of MimviApps today. MimviApps aims to deliver high-quality apps to the local and small business market at a fraction of the cost of custom development. Offering three packages, the most popular being the native iPhone, iPad, and Android apps, with a mobile website for $999. Mimvi is also offering a $500 coupon for the first 60 days, bringing the initial setup price down by almost half. "Apps are the new websites," said Mimvi CEO Michael Poutre. "Virtually every business will need to have an app, and…

Continue Reading

FridayApr 26, 2013 10:55 am

Ampio Pharmaceuticals, Inc. (AMPE) Announces Enrollment Completion for Run-In SPRING Study of Ampion in Osteoarthritis of the Knee

Development-stage biopharmaceutical company Ampio Pharmaceuticals announced it has completed patient enrollment for a dose-escalation run-in study to a Phase III pivotal trial evaluating Ampion for the treatment of moderate to severe osteoarthritis of the knee. It is anticipated that 12-week primary endpoint data will be available in the third quarter of 2013. Ampion is being evaluated in the SPRING trial for its pain-reducing effect as a single intra-articular injection into the knee in 4 mL and 10 mL volumes, as compared with placebo at 12 weeks. More than the targeted 320 patients have been enrolled in the study, which is…

Continue Reading

FridayApr 26, 2013 8:57 am

Catasys, Inc. (CATS) CEO Dr. Manejwala to Present at American Society of Medicine Conference

Catasys, a provider of specialized health management services for health insurers and employers, reports that company CEO Omar Manejwala, M.D., will deliver a presentation at the American Society of Addiction Medicine’s (ASAM) 44th annual medical-scientific conference, “New Treatments in Addiction Medicine,” held April 25 – 28, 2013, in Chicago. ASAM is a professional society representing more than 3,000 physicians focused on enhancing access and quality of addiction treatment, as well as educating physicians and the public and supporting research and prevention. Dr. Manejwala, who oversees medical affairs at Catasys, will highlight innovation in clinical improvements in substance dependent populations in…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered